CD8A and neoplasm: We conducted a systematic analysis of the risk and high-risk groups in terms of immune infiltration and found that patients in the low-risk group had higher levels of plasma cells and CD8+ T cells, indicating a better immune response against tumor cells (Kondratiev et al., 2004).